Historical Valuation
Privia Health Group Inc (PRVA) is now in the Fair zone, suggesting that its current forward PS ratio of 1.29 is considered Fairly compared with the five-year average of 47.75. The fair price of Privia Health Group Inc (PRVA) is between 18.54 to 43.87 according to relative valuation methord.
Relative Value
Fair Zone
18.54-43.87
Current Price：23.04
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Privia Health Group Inc (PRVA) has a current Price-to-Book (P/B) ratio of 4.06. Compared to its 3-year average P/B ratio of 4.58 , the current P/B ratio is approximately -11.34% higher. Relative to its 5-year average P/B ratio of 6.17, the current P/B ratio is about -34.12% higher. Privia Health Group Inc (PRVA) has a Forward Free Cash Flow (FCF) yield of approximately 3.84%. Compared to its 3-year average FCF yield of 2.93%, the current FCF yield is approximately 31.14% lower. Relative to its 5-year average FCF yield of 2.39% , the current FCF yield is about 60.65% lower.
P/B
Median3y
4.58
Median5y
6.17
FCF Yield
Median3y
2.93
Median5y
2.39
Competitors Valuation Multiple
AI Analysis for PRVA
The average P/S ratio for PRVA competitors is 0.84, providing a benchmark for relative valuation. Privia Health Group Inc Corp (PRVA.O) exhibits a P/S ratio of 1.29, which is 54.27% above the industry average. Given its robust revenue growth of 32.54%, this premium appears sustainable.
Performance Decomposition
AI Analysis for PRVA
1Y
3Y
5Y
Market capitalization of PRVA increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of PRVA in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is PRVA currently overvalued or undervalued?
Privia Health Group Inc (PRVA) is now in the Fair zone, suggesting that its current forward PS ratio of 1.29 is considered Fairly compared with the five-year average of 47.75. The fair price of Privia Health Group Inc (PRVA) is between 18.54 to 43.87 according to relative valuation methord.
What is Privia Health Group Inc (PRVA) fair value?
PRVA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Privia Health Group Inc (PRVA) is between 18.54 to 43.87 according to relative valuation methord.
How does PRVA's valuation metrics compare to the industry average?
The average P/S ratio for PRVA's competitors is 0.84, providing a benchmark for relative valuation. Privia Health Group Inc Corp (PRVA) exhibits a P/S ratio of 1.29, which is 54.27% above the industry average. Given its robust revenue growth of 32.54%, this premium appears sustainable.
What is the current P/B ratio for Privia Health Group Inc (PRVA) as of Jan 12 2026?
As of Jan 12 2026, Privia Health Group Inc (PRVA) has a P/B ratio of 4.06. This indicates that the market values PRVA at 4.06 times its book value.
What is the current FCF Yield for Privia Health Group Inc (PRVA) as of Jan 12 2026?
As of Jan 12 2026, Privia Health Group Inc (PRVA) has a FCF Yield of 3.84%. This means that for every dollar of Privia Health Group Inc’s market capitalization, the company generates 3.84 cents in free cash flow.
What is the current Forward P/E ratio for Privia Health Group Inc (PRVA) as of Jan 12 2026?
As of Jan 12 2026, Privia Health Group Inc (PRVA) has a Forward P/E ratio of 90.75. This means the market is willing to pay $90.75 for every dollar of Privia Health Group Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Privia Health Group Inc (PRVA) as of Jan 12 2026?
As of Jan 12 2026, Privia Health Group Inc (PRVA) has a Forward P/S ratio of 1.29. This means the market is valuing PRVA at $1.29 for every dollar of expected revenue over the next 12 months.